Pharma Focus Asia
MasterControl - Avoid Falling Behind the Pharma Market

CanariaBio Receives FDA Orphan Drug Designation for MAb-AR20.5 in Pancreatic Cancer

Tuesday, August 22, 2023

CanariaBio announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to their investigational drug product, MAb-AR20.5.

MAb-AR20.5 is a monoclonal antibody that specifically targets the MUC1 antigen, which is expressed on pancreatic cancer cells. This type of targeted therapy has the potential to be more effective and have fewer side effects compared to traditional treatments that affect healthy cells as well. 

The antibody has shown promise in early studies by inducing immune responses specific to the MUC1 antigen in patients with advanced pancreatic cancer. This is important because pancreatic cancer is known to be a challenging malignancy with limited treatment options available, and any new treatment strategies are welcomed advancements.

Overall, the development of MAb-AR20.5 as a potential treatment for pancreatic cancer is promising news, offering hope for patients and potentially improving the outlook for those affected by this aggressive disease. 

The orphan drug designation suggests that MAb-AR20.5 is being recognized for its potential to address an unmet medical need, particularly for patients with pancreatic cancer. 

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Increasing the likelihood of your drug approvalMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® productsMedical Fair Thailand 20235th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023
MasterControl - 6 Essential Features in an eQMS